Advertisement
Advertisement
KMDA
Kamada Ltd
7.71
USDSponsored
+0.48
+6.64%
Nov 09, 15:58 UTC -5
Closed
After-Market
7.69
-0.02
-0.26%
Kamada Ltd (KMDA) Earnings
KMDA Earnings Reports
Positive Surprise Ratio
KMDA beat 26 of 43 last estimates.
60%
Next Report
Date of Next Report
Mar 09, 2027
Estimate for Q4 26 (Revenue/ EPS)
$51.29M
/$0.12
Implied change from Q3 26 (Revenue/ EPS)
-1.42%
/-14.29%
Implied change from Q4 25 (Revenue/ EPS)
+14.80%
/+100.00%
Kamada Ltd earnings per share and revenue
On Nov 09, 2026, KMDA reported earnings of 0.14 USD per share (EPS) for Q3 26, beating the estimate of 0.13 USD, resulting in a 7.61% surprise. Revenue reached 52.03 million, compared to an expected 53.56 million, with a -2.85% difference.
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.12 USD, with revenue projected to reach 51.29 million USD, implying an decrease of -14.29% EPS, and decrease of -1.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bicara Therapeutics Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.84
Actual
-$1.04
Surprise
-23.02%
Compugen Ltd
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Spruce Biosciences, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$5.78
Actual
-$8.51
Surprise
-47.00%
Rani Therapeutics Holdings, Inc. Class A Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.04
Surprise
+17.53%
TG Therapeutics, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.37
Actual
$0.35
Surprise
-6.44%
Immunovant, Inc. Common Stock
Report Date
Nov 09, 2026 For Q2 27
Estimate
-$0.74
Actual
-$0.47
Surprise
+37.07%
Xenon Pharmaceuticals Inc
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$1.15
Actual
-$1.11
Surprise
+4.03%
AbCellera Biologics Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.13
Surprise
+24.15%
Trevi Therapeutics, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.13
Surprise
+5.39%
Impact BioMedical, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-Actual
-$0.08
Surprise
-
FAQ
What were Kamada Ltd's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Kamada Ltd reported EPS of $0.14, beating estimates by 7.61%, and revenue of $52.03M, -2.85% below expectations.
How did the market react to Kamada Ltd's Q3 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Kamada Ltd expected to report next?
The next earning report is scheduled for Mar 09, 2027.
What are the forecasts for Kamada Ltd's next earnings report?
Based on --
analysts, Kamada Ltd is expected to report EPS of $0.12 and revenue of $51.29M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.